In honour of International Women's Day (IWD), Praxis recognizes the significant contributions women make across the globe. Our admiration and gratitude goes…
Praxis Spinal Cord Institute is pleased to announce the three transformative technologies selected as the SCI Incubate program cohort for 2023. Three companies— Battelle, inContAlert, and Focal…
Indigenous Canadians experience greater challenges living with spinal cord injury (SCI) than the rest of the population. Since our unique Praxis model…
Praxis commercialization program alum, Kalogon has developed a pressure-relieving cushion that helps wheelchair users avoid pressure injuries and pain. Machine learning helps…
Rehabtronics, a BC-based medical start-up and inaugural Praxis SCI Accelerate program alum, has developed a novel neurostimulation medical device to treat and…
Inteligex is a Canadian biotechnology company developing effective regenerative medicine treatments for SCI and many other CNS diseases. Inteligex has developed two proprietary…
